Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics (Nasdaq: NTLA) announced on March 6, 2026 that it granted inducement awards to six new employees under its 2024 Inducement Plan.

Rhea-AI Summary

Intellia Therapeutics (Nasdaq: NTLA) announced on March 6, 2026 that it granted inducement awards to six new employees under its 2024 Inducement Plan.

The awards were time-based restricted stock units totaling 16,500 shares, with one-third vesting annually over three years, granted March 1, 2026 and approved under Nasdaq Listing Rule 5635(c)(4).

Argus Mar 9 session

+3.35% close to close Open Argus

Details

News Market Reaction – NTLA

On Mar 9, the first trading day after this news, NTLA closed 3.35% above the previous close.

Data tracked by StockTitan Argus for the Mar 9 session.

Key Figures

Inducement RSUs: 16,500 shares Vesting period: 3 years Current price: $13.15 +5 more

Inducement RSUs

16,500 shares

Aggregate RSUs granted to six new employees on March 1, 2026

Vesting period

3 years

One-third of RSUs vest annually over three years

Current price

$13.15

Pre-news trading level on publication date

Price change 24h

-4.85%

Move in the prior 24 hours before this announcement

52-week high

$28.25

52-week high price prior to this news

52-week low

$5.90

52-week low price prior to this news

ATM offering size

$400,000,000

Common stock under 424B5 at-the-market program with Jefferies

ATM commission

3.0%

Commission on gross proceeds to Jefferies as sales agent

Historical Context

5 past events · Latest: Mar 03

5 events

1. Mar 03

   Clinical data update

   24h Move

   -11.9%

   Longer-term Phase 1/2 lonvo-z HAE data with durable attack reduction.

2. Mar 02

   Regulatory trial update

   24h Move

   +12.1%

   FDA lifted clinical hold on MAGNITUDE Phase 3 ATTR-CM trial.

3. Feb 26

   Earnings and pipeline

   24h Move

   +6.4%

   Q4/FY 2025 results, cash of $605.1M, and HAELO Phase 3 timeline.

4. Feb 24

   Investor conferences

   24h Move

   +3.2%

   Participation in multiple March 2026 healthcare investor conferences.

5. Feb 19

   Earnings call notice

   24h Move

   +4.5%

   Scheduled call to discuss Q4 and full-year 2025 results and updates.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

restricted stock units, RSUs, Nasdaq Listing Rule 5635(c)(4), equity incentive plans

4 terms

restricted stock units financial

"The inducement grants consisted of time-based restricted stock units (“RSUs”) for an aggregate..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"time-based restricted stock units (“RSUs”) for an aggregate of 16,500 shares of Intellia’s common stock..."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Nasdaq Listing Rule 5635(c)(4) regulatory

"awards were approved... in accordance with Nasdaq Listing Rule 5635(c)(4)."

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

equity incentive plans financial

"awards were granted outside of Intellia’s stockholder-approved equity incentive plans pursuant..."

Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on March 1, 2026, it awarded inducement grants to six new employees under Intellia’s 2024 Inducement Plan as a material inducement to employment.

The inducement grants consisted of time-based restricted stock units (“RSUs”) for an aggregate of 16,500 shares of Intellia’s common stock, with one-third of such RSUs vesting annually over three years. All equity vesting is subject to each employee’s continued service as an employee of, or other service provider to, Intellia through the applicable vesting dates.

All of the above-described awards were granted outside of Intellia’s stockholder-approved equity incentive plans pursuant to Intellia’s 2024 Inducement Plan, which was adopted by the board of directors in June 2024. These awards were approved by Intellia’s compensation committee as a material inducement to entering into employment with Intellia in accordance with Nasdaq Listing Rule 5635(c)(4).

About Intellia Therapeutics

Intellia Therapeutics, Inc. (Nasdaq: NTLA) is a leading clinical-stage biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies. The company’s mission is to transform the lives of people with severe diseases by developing and commercializing potentially curative treatments. With deep scientific, technical and clinical development experience, Intellia aims to reset the standard for medicine by durably treating the root causes of disease. Learn more at intelliatx.com and follow us @intelliatx.

Contact:

Jason Fredette
Vice President, Investor Relations and Corporate Communications
Intellia Therapeutics, Inc.
jason.fredette@intelliatx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Intellia (NTLA) announce on March 6, 2026 about inducement grants?

Intellia announced inducement awards to six new employees totaling 16,500 RSUs. According to the company, the awards were granted March 1, 2026 under the 2024 Inducement Plan and approved by the compensation committee as a material inducement to employment.

How many shares and what vesting schedule did NTLA grant in the inducement awards?

Intellia granted an aggregate of 16,500 time-based RSUs with one-third vesting annually over three years. According to the company, vesting is subject to continued service through each applicable vesting date and the awards were granted outside stockholder-approved plans.

Were the NTLA inducement grants approved under Nasdaq rules and why?

Yes, the compensation committee approved the awards as a material inducement under Nasdaq Listing Rule 5635(c)(4). According to the company, that approval authorized grants outside of existing stockholder-approved equity incentive plans pursuant to the 2024 Inducement Plan.

Who received the inducement grants from Intellia (NTLA) and under which plan were they issued?

Six new employees received the inducement awards under Intellia’s 2024 Inducement Plan. According to the company, the awards were issued outside its stockholder-approved equity incentive plans and adopted by the board in June 2024.

Do the 16,500 RSUs from NTLA immediately vest or affect shareholder voting rights?

The RSUs do not immediately vest; one-third vests annually over three years and vesting requires continued service. According to the company, these are time-based RSUs and vesting is subject to employment or service through each vesting date.